首页> Vaccine> Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.

Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.

导出 OA

翻译打印收藏纠错

第一作者： Qiu-Dong,Su

第一单位： National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China.

作者： Qiu-Dong,Su ^[1] ; Ye-Ning,Zou ^[2] ; Yao,Yi ^[1] ; Li-Ping,Shen ^[1] ; Xiang-Zhong,Ye ^[3] ; Yang,Zhang ^[4] ; Hui,Wang ^[4] ; Hong,Ke ^[4] ; Jing-Dong,Song ^[1] ; Ke-Ping,Hu ^[5] ; Bo-Lin,Cheng ^[6] ; Feng,Qiu ^[1] ; Peng-Cheng,Yu ^[1] ; Wen-Ting,Zhou ^[1] ; Ran,Zhao ^[2] ; Lei,Cao ^[1] ; Gao-Feng,Dong ^[7] ; Sheng-Li,Bi ^[8] ; Gui-Zhen,Wu ^[1] ; George Fu,Gao ^[1] ; Jerry,Zheng ^[4]

作者单位： National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China. ^[1] Sinovac Biotech Co., Ltd, Beijing 100085, China. ^[2] Beijing WanTai Biological Pharmacy Enterprise Co., Ltd, Beijing 102206, China. ^[3] Artron Bioresearch Inc., Burnaby, BC V5A1M6, Canada. ^[4] Institute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100193, China. ^[5] Jianxuan Business Center, Tianjin 300110, China. ^[6] Sinovac Life Sciences Co., Ltd, Beijing 100085, China. ^[7] National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China. Electronic address: bisl@ivdc.chinacdc.cn. ^[8]

关键词 RBD SARS-CoV-2 Subunit vaccine TT peptide